| Kyverna Therapeutics, Inc. |
10%+ Owner |
Common Stock |
4,523,924 |
|
|
12 Feb 2024 |
By Vida Ventures, LLC |
| Kyverna Therapeutics, Inc. |
10%+ Owner |
Common Stock |
252,553 |
|
|
12 Feb 2024 |
By Vida Ventures III, L.P. |
| Kyverna Therapeutics, Inc. |
10%+ Owner |
Common Stock |
583 |
|
|
12 Feb 2024 |
By Vida Ventures III-A, L.P. |
| Kyverna Therapeutics, Inc. |
10%+ Owner |
Series A-1 Redeemable Convertible Preferred Stock |
0 |
|
|
12 Feb 2024 |
By Vida Ventures, LLC |
| Kyverna Therapeutics, Inc. |
10%+ Owner |
Series A-2 Redeemable Convertible Preferred Stock |
0 |
|
|
12 Feb 2024 |
By Vida Ventures, LLC |
| Kyverna Therapeutics, Inc. |
10%+ Owner |
Series B Redeemable Convertible Preferred Stock |
0 |
|
|
12 Feb 2024 |
By Vida Ventures, LLC |